2-Hydroxy-2-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-acetamide

ID: ALA2324117

PubChem CID: 71601790

Max Phase: Preclinical

Molecular Formula: C20H16N4O3

Molecular Weight: 360.37

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cn1cc(-c2cnc3ccc4ccc(C(O)C(N)=O)cc4c(=O)c3c2)cn1

Standard InChI:  InChI=1S/C20H16N4O3/c1-24-10-14(9-23-24)13-7-16-17(22-8-13)5-4-11-2-3-12(18(25)20(21)27)6-15(11)19(16)26/h2-10,18,25H,1H3,(H2,21,27)

Standard InChI Key:  NPKHYQHLPSZNHP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    5.9940  -17.7079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5696  -19.4924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3877  -19.4982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7257  -18.0695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9050  -18.8671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6839  -19.1091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2842  -18.5545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1003  -17.7548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3217  -17.5165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0655  -18.8475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2572  -18.0515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6645  -17.4894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8797  -17.7222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6911  -18.5221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2853  -19.0807    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0032  -16.8907    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2864  -17.1569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3912  -16.3465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6529  -15.9963    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0916  -16.5904    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4832  -17.3076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2812  -16.4855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6983  -17.1978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4796  -17.4372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0776  -16.8802    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6630  -18.2336    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5149  -16.4015    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 11  1  1  0
  1  4  1  0
 10  2  1  0
  5  3  1  0
  2  3  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  1 16  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 17  2  0
 13 17  1  0
 20 22  1  0
  8 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 23 27  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA2324117

   2-Hydroxy-2-[5-(1-methylpyrazol-4-yl)-2-oxo-7-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-14-yl]acetamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 360.37

Molecular Weight (Monoisotopic): 360.1222

AlogP: 1.67

#Rotatable Bonds: 3

Polar Surface Area: 111.10

Molecular Species: NEUTRAL

HBA: 6

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 12.34

CX Basic pKa: 3.07

CX LogP: 1.01

CX LogD: 1.01

Aromatic Rings: 4

Heavy Atoms: 27

QED Weighted: 0.58

Np Likeness Score: -0.86

References

1. Northrup AB, Katcher MH, Altman MD, Chenard M, Daniels MH, Deshmukh SV, Falcone D, Guerin DJ, Hatch H, Li C, Lu W, Lutterbach B, Allison TJ, Patel SB, Reilly JF, Reutershan M, Rickert KW, Rosenstein C, Soisson SM, Szewczak AA, Walker D, Wilson K, Young JR, Pan BS, Dinsmore CJ..  (2013)  Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-Met.,  56  (6): [PMID:23379595] [10.1021/jm301619u]

Source

Source(1):

• Scientific Literature